US BANCORP \DE\

Q1 2021 13F-HR Detailed Holdings

Location
Minneapolis, MN
Holdings as of
3/31/2021
Date filed
4/28/2021
Form type
13F-HR
Num holdings
7,406
Total value ($000)
$49,442,337
Net value change ($000)
+3,009,109 (6.5%)
New positions
267
Sold out positions
146
Turnover %
0.2%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q4 2020
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
IWR 275,916 28.0%
IVV 219,790 13.8%
IEFA 168,553 15.6%
JPM 104,535 21.6%
IEMG 103,286 12.1%
SPY 99,700 4.9%
IWM 95,502 24.3%
VNQ 80,208 19.7%
GOOGL 79,853 16.4%
MSFT 77,567 5.8%
Top Reduces (Value $000, Stocks/ETFs)
AAPL -153,747 -9.1%
CPRT -103,930 -21.1%
QQQ -41,692 -6.5%
USMV -37,996 -17.1%
UPS -26,941 -25.4%
AMZN -26,232 -2.9%
PEP -25,116 -7.8%
NKE -24,089 -13.1%
GOVT -23,773 -39.2%
GLD -22,396 -17.7%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 2,089 (0.0% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 US BANK NATIONAL ASSOCIATION 028-02267
5 U.S. BANCORP INVESTMENTS, INC. 028-16147